News: Front Section
Posted: February 23, 2024
Shawmut Design and Construction grows with addition of strategic development leaders in New England
Boston, MA Shawmut Design and Construction, a leading $1.6 billion national construction management firm, is hiring two experienced business development directors to its New England region. Michael Christopher, a former leader at the Boston Planning & Development Agency (BPDA), and Caren Jenkins, a longtime client strategist in the pharma/biopharma industry, will help Shawmut’s strategic growth plan to drive increased market share of projects in the commercial, life sciences/advanced technology, and education sectors.
“We are excited to welcome Michael and Caren. They are demonstrated leaders in the region and their expertise fits precisely with our dedication to having the most skilled talent to support our partners’ visions and deliver exceptional building experiences,” said Kevin Sullivan, executive vice president of Shawmut’s New England region.
Christopher most recently served as the director of development review at the Boston Planning & Development Agency, where he provided direction for the review of development proposals from commercial and non-profit entities seeking to renovate and/or construct commercial, industrial, institutional, residential, and mixed-use projects in Boston. Under his leadership, more than 65 million s/f of new development space was permitted since 2016, with total investment exceeding $36 billion.
"I have long-admired Shawmut as a renowned industry leader in New England. As an employee-owned company with roots in the City of Boston, Shawmut's commitment to excellence and community resonates deeply with me. I look forward to contributing to its continued success and growth,” Christopher said.
Jenkins most recently served as client strategist at CRB, a design, engineering, construction, and consulting firm specializing in life sciences. Her career spans more than 15 years with a focus on executing client pursuit and business development strategies across the AEC, life sciences, biopharma manufacturing, and biotech industries.
“In the life sciences/advanced technology industry, Shawmut has a hard-earned reputation as an innovator and reliable business partner. I am eager to continue building that legacy and growing footprint in the region,” Jenkins said.
Christopher and Jenkins join Jeff Cammuso, a 17-year industry veteran, as the firm’s business development leads in its New England region.
Tags:
Front Section
MORE FROM Front Section
Newmark negotiates sale of 10 Liberty Sq. and 12 Post Office Sq.
Boston, MA Newmark has completed the sale of 10 Liberty Sq. and 12 Post Office Sq. Newmark co-head of U.S. Capital Markets Robert Griffin and Boston Capital Markets executive vice chairman Edward Maher, vice chairman Matthew Pullen, executive managing director James Tribble,
.png)
Quick Hits
Columns and Thought Leadership
Make PR pop by highlighting unique angles - by Stanley Hurwitz
Coming out of the pandemic, a client with three hotels in Provincetown, Mass., needed ways to let the world know his properties were open for business for the 2021 tourist season.
Five ways to ruin a Section 1031 Like-Kind Exchange - by Bill Lopriore
While there is some flexibility when structuring a like-kind exchange, some important requirements must be met. A mistake can ruin your exchange. Here are five mistakes to avoid:
Four tips for a smooth 1031 Exchange - by Bill Lopriore
Many real estate investors do not understand the specific requirements that must be met to secure the benefits of a tax-deferred 1031 exchange. For example, the replacement property must be identified within 45 days of the closing date of the relinquished property.
How COVID-19 has impacted office leasing - by Noble Allen and John Sokul
To say that the effects of COVID-19 has transformed office leasing is an understatement. When COVID-19 was at its peak, office spaces were practically abandoned either through governmental mandates or through actions taken by businesses themselves.